Vicarious Surgical Inc (NYSE:RBOT) CEO Sells $13,701.79 in Stock

Vicarious Surgical Inc (NYSE:RBOT) CEO Adam David Sachs sold 943 shares of the firm’s stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $14.53, for a total transaction of $13,701.79. Following the completion of the transaction, the chief executive officer now directly owns 52,699 shares in the company, valued at $765,716.47. This trade represents a 1.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Adam David Sachs also recently made the following trade(s):

• On Monday, December 23rd, Adam David Sachs sold 139 shares of Vicarious Surgical stock. The shares were sold at an average price of $12.27, for a total value of $1,705.53.
• On Tuesday, December 3rd, Adam David Sachs sold 463 shares of Vicarious Surgical stock. The stock was sold at an average price of $13.50, for a total value of $6,250.50.

Vicarious Surgical Trading Down 1.6 %

Shares of NYSE RBOT opened at $14.38 on Monday. The stock has a market capitalization of $84.99 million, a PE ratio of -1.40 and a beta of 1.32. The stock has a fifty day simple moving average of $13.65 and a 200-day simple moving average of $10.14. Vicarious Surgical Inc has a twelve month low of $4.27 and a twelve month high of $19.00.

Analyst Upgrades and Downgrades

Separately, Piper Sandler cut their target price on Vicarious Surgical from $12.00 to $10.50 and set a “neutral” rating for the company in a research note on Wednesday, November 13th.

Institutional Trading of Vicarious Surgical

Hedge funds have recently added to or reduced their stakes in the company. Renaissance Technologies LLC lifted its position in Vicarious Surgical by 11.6% in the fourth quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after acquiring an additional 1,200 shares during the last quarter. DnB Asset Management AS grew its stake in shares of Vicarious Surgical by 21.1% in the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after purchasing an additional 3,692 shares during the last quarter. Finally, Geode Capital Management LLC lifted its stake in shares of Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock worth $405,000 after acquiring an additional 2,336 shares during the period. Institutional investors and hedge funds own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.